ASTCT Review of Key Proposed Changes in FY2021 IPPS for CAR-T and Allogeneic HCT
- Non-member - Free!
- Member - Free!
This webinar aired on May 19, 2020. Topics covered in this webinar include:
A breakdown of what CMS has proposed
New CAR-T MS-DRG 018
Elimination of NTAP
Impact of adjustments and outlier policy
Proposed payment method for CAR-T clinical trial cases
Overview of the reasonable cost reimbursement methodology for reimbursement of allogeneic stem cell transplants
Round up of other major proposed changes
Initial feedback/thoughts about advocacy implications
The speakers will also walk through a two-hospital CAR-T reimbursement scenario to give hospitals a feel for the financial impact of CMS’ proposals relative to today’s payment.